Augmented Therapy Improves Outcome For Pediatric High Risk Acute Lymphocytic Leukemia: Results Of Children’s Oncology Group Trial P9906

BACKGROUND: The augmented BFM regimen improves outcome for children with NCI high acute lymphoblastic leukemia (ALL). Patient age, sex, and presenting white blood cell count (WBC) can be used to identify a subset of approximately 12% of children with B-precursor ALL that had a 5-year continuous comp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bowman, W. Paul, Larsen, Eric L, Devidas, Meenakshi, Linda, Stephen B., Blach, Laurie, Carroll, Andrew J, Carroll, William L, Pullen, D. Jeanette, Shuster, Jonathan, Willman, Cheryl L, Winick, Naomi, Camitta, Bruce M, Hunger, Stephen P, Borowitz, Michael J
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3136564/
https://ncbi.nlm.nih.gov/pubmed/21360654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22944
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados